Literature DB >> 12099288

A method to fabricate porous spherical hydroxyapatite granules intended for time-controlled drug release.

Vladimir S Komlev1, Serguei M Barinov, Elena V Koplik.   

Abstract

This study is aimed at the development of a method to fabricate porous spherical hydroxyapatite (HA) granules, which can be impregnated with a drug. These drug-loaded particles can be used as a system for targeted and time-controlled drug delivery, e.g. in bone surgery. The method to produce porous granules is based on liquids immiscibility effect. A suspension of HA powder in aqueous solution of gelatin and oil as a dispersion media were used. By stirring the mixtures of these immiscible liquids, granules of 50 2,000 microm diameter can easily be produced. Dependence of the granules characteristics on the preparation route was studied. In vivo experiments were performed to simulate drug release kinetics from the granules to the blood of rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099288     DOI: 10.1016/s0142-9612(02)00049-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

1.  Synthesis and hydrothermal treatment of nanostructured hydroxyapatite of controllable sizes.

Authors:  Say Chye Joachim Loo; Yiwei Eva Siew; Shuhui Ho; Freddy Yin Chiang Boey; J Ma
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

2.  Effects of calcination temperature on the drug delivery behaviour of Ibuprofen from hydroxyapatite powders.

Authors:  Amanda J Melville; Luis M Rodríguez-Lorenzo; John S Forsythe
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

3.  Preparation and characterisation of calcium-phosphate porous microspheres with a uniform size for biomedical applications.

Authors:  C C Ribeiro; C C Barrias; M A Barbosa
Journal:  J Mater Sci Mater Med       Date:  2006-05       Impact factor: 3.896

4.  Macro-to-micro porous special bioactive glass and ceftriaxone-sulbactam composite drug delivery system for treatment of chronic osteomyelitis: an investigation through in vitro and in vivo animal trial.

Authors:  Biswanath Kundu; Samit Kumar Nandi; Sudip Dasgupta; Someswar Datta; Prasenjit Mukherjee; Subhasis Roy; Aruna Kumari Singh; Tapan Kumar Mandal; Partha Das; Rupnarayan Bhattacharya; Debabrata Basu
Journal:  J Mater Sci Mater Med       Date:  2011-01-08       Impact factor: 3.896

5.  Chitosan impregnation with biologically active tryaryl imidazoles in supercritical carbon dioxide.

Authors:  Anastasia V Cherkasova; Nikolay N Glagolev; Andrey I Shienok; Tatiana S Demina; Svetlana L Kotova; Natalia L Zaichenko; Tatiana A Akopova; Peter S Timashev; Victor N Bagratashvili; Anna B Solovieva
Journal:  J Mater Sci Mater Med       Date:  2016-08-18       Impact factor: 3.896

6.  Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release.

Authors:  Hae-Won Kim; Jonathan C Knowles; Hyoun-Ee Kim
Journal:  J Mater Sci Mater Med       Date:  2005-03       Impact factor: 3.896

7.  Mesoporous Iron(III)-Doped Hydroxyapatite Nanopowders Obtained via Iron Oxalate.

Authors:  Margarita A Goldberg; Marat R Gafurov; Fadis F Murzakhanov; Alexander S Fomin; Olga S Antonova; Dinara R Khairutdinova; Andrew V Pyataev; Olga N Makshakova; Anatoliy A Konovalov; Alexander V Leonov; Suraya A Akhmedova; Irina K Sviridova; Natalia S Sergeeva; Sergey M Barinov; Vladimir S Komlev
Journal:  Nanomaterials (Basel)       Date:  2021-03-22       Impact factor: 5.076

8.  Preparation and physico-chemical characterisation of microporous polysaccharidic hydrogels.

Authors:  Gemma Leone; Rolando Barbucci; Assunta Borzacchiello; Luigi Ambrosio; Paolo A Netti; Claudio Migliaresi
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

9.  BCP ceramic microspheres as drug delivery carriers: synthesis, characterisation and doxycycline release.

Authors:  Sunita Prem Victor; T S Sampath Kumar
Journal:  J Mater Sci Mater Med       Date:  2007-06-28       Impact factor: 3.896

10.  Silica xerogel-chitosan nano-hybrids for use as drug eluting bone replacement.

Authors:  Eun-Jung Lee; Shin-Hee Jun; Hyoun-Ee Kim; Hae-Won Kim; Young-Hag Koh; Jun-Hyeog Jang
Journal:  J Mater Sci Mater Med       Date:  2009-08-06       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.